Not applicableNot Yet RecruitingNCT07758127What this trial is testingUpdates and Insights on HER2 in Breast Cancer in Sohag GovernorateWho this might be right forHER2 Status in Breast Cancer Sohag University 100
Testing effectiveness (Phase 2)UnknownNCT04318223What this trial is testingPalbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal TherapyWho this might be right forMetastatic Breast CancerLocally Advanced Breast Cancer Consorzio Oncotech 168
Testing effectiveness (Phase 2)Study completedNCT00284180What this trial is testingVinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast CancerWho this might be right forBreast NeoplasmsBreast Cancer SCRI Development Innovations, LLC 32
Not applicableStudy completedNCT01075386What this trial is testingThe Effects of the Endocrine System on Endometrial CancerWho this might be right forEndometrial Cancer Queensland Centre for Gynaecological Cancer 75
Not applicableStudy completedNCT00193934What this trial is testingMagnetic Resonance Imaging (MRI) Staging of Cervix CancerWho this might be right forCancer of the Uterine Cervix Trans Tasman Radiation Oncology Group 109
Testing effectiveness (Phase 2)Study completedNCT01469000What this trial is testingPemetrexed and Gefitinib Versus Gefitinib in Non-Small Cell Lung Cancer (NSCLC)Who this might be right forCarcinoma, Non Small Cell Lung Eli Lilly and Company 195
Not applicableLooking for participantsNCT06703736What this trial is testingFunctional and Morphological Characterization of Multiple Osteochondromas DisorderWho this might be right forHereditary Multiple Osteochondromas Istituto Ortopedico Rizzoli 60
Early research (Phase 1)Study completedNCT01007032What this trial is testingIMC-A12 in Advanced Solid TumorsWho this might be right forTumors Eli Lilly and Company 21
Large-scale testing (Phase 3)Ended earlyNCT00968968What this trial is testingContinued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab AloneWho this might be right forCancer Novartis Pharmaceuticals 37
Testing effectiveness (Phase 2)Study completedNCT02264210What this trial is testingIcotinib for Completed Resected IB NSCLC With EGFR MutationWho this might be right forLung NeoplasmsSquamous Cell Lung CancerAdenocarcinoma of the Lung+4 more Sun Yat-sen University 128
Testing effectiveness (Phase 2)Ended earlyNCT00591149What this trial is testingOxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck CancerWho this might be right forHead and Neck CancerCarcinoma, Squamous University of Kansas Medical Center 16
Testing effectiveness (Phase 2)Study completedNCT01070355What this trial is testingEicosapentaenoic Acid (EPA) for Treatment of Colorectal Cancer Liver MetastasesWho this might be right forColorectal Cancer University of Leeds 88
Testing effectiveness (Phase 2)Ended earlyNCT03519178What this trial is testingPF-06873600 in People With CancerWho this might be right forHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer Pfizer 155
Not applicableStudy completedNCT01015625What this trial is testingPrimary Operation in SYnchronous meTastasized InVasivE Breast CancerWho this might be right forSynchronous Metastasized Breast CancerCirculating Tumor Cells Austrian Breast & Colorectal Cancer Study Group 90
Post-approval studies (Phase 4)Not Yet RecruitingNCT07630948What this trial is testingAdherence and Safety of Ribociclib Plus Aromatase Inhibitors in Patients With Early Stage, HR+ and HER2- Breast CancerWho this might be right forBreast CancerAdherence, Medication Institute of Oncology Ljubljana 90
Large-scale testing (Phase 3)Study completedNCT00373425What this trial is testingErlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive TumorsWho this might be right forNon-small Cell Lung Cancer OSI Pharmaceuticals 1,252
Early research (Phase 1)Study completedNCT02045368What this trial is testingStudy of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1RWho this might be right forBreast CancerBrain CancerGastrointestinal Cancers+5 more IGF Oncology, LLC 92
Large-scale testing (Phase 3)Ended earlyNCT01377376What this trial is testingA Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study of ARQ 197 Plus Erlotinib Versus Placebo Plus ErlotinibWho this might be right forNon-small-cell Lung Cancer Kyowa Kirin Co., Ltd.
Early research (Phase 1)UnknownNCT03503604What this trial is testingAnti-VEGF Monoclonal Antibody hPV19 in Patients With Solid TumorsWho this might be right forSolid Tumors SuZhou Stainwei Biotech Inc. 18
Testing effectiveness (Phase 2)Ended earlyNCT00778817What this trial is testingIMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by SurgeryWho this might be right forRecurrent Adrenocortical CarcinomaStage III Adrenocortical CarcinomaStage IV Adrenocortical Carcinoma National Cancer Institute (NCI) 20